Fundraising Fox

Cathay Health

Venture capital

San Francisco · Seed–Late Stage · 1 people tracked

Also known as CATHAY CAPITAL NA, LLC

Fox Verdict
Sign up to see your fit

Investment thesis

Cathay Health invests in companies operating at the convergence of life sciences, healthcare, and technology, targeting positive impact on human health. Its focus areas include life science tools, diagnostics, clinical trial innovation, new care models, novel devices and materials, and enabling technologies for advanced therapies. The firm both invests in and operates at this convergence, backing businesses spanning surgical robotics, biomaterials, gene and cell therapy manufacturing, and health tech venture creation.

Invests inAdvanced ManufacturingBiotechConsumerCrypto & Web3Deep TechDigital HealthHealthtechMedical DevicesNew MaterialsRoboticsAsia-PacificChinaEuropeFranceGlobalNorth AmericaParisSan FranciscoSwitzerlandUnited KingdomUnited States

Source: firm website, verified Aug 11, 2026.

Stage
Seed–Late Stage
HQ
San Francisco, NY, US
Instruments
Equity
Founded
2021
AUM
$76.6M
Tracked investments
5

Team · 1 people

from public directories

What they invest in

from 3 of 5 portfolio companies

Medical Devices ×3Biotech ×2Healthtech ×2Deep Tech ×1New Materials ×1Robotics ×1

HQs:Germany×1France×1United States×1

Investments · 5 tracked

founders shown can be your intro path
Ascend Advanced Therapiesascend-adv.comin

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.

BiotechHealthtechMedical DevicesMunich, DE

PartnerEric De La Fortelle· solo GP

Ganymed Roboticsganymedrobotics.com

PartnerEric De La Fortelle· solo GP

Initiate Studioinitiate.studio

PartnerEric De La Fortelle· solo GP

Moon Surgicalmoonsurgical.comin𝕏

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

Anne Osdoit(Chief Executive Officer)inFred Moll(Board Chair)Brice Gayet(Founder)Eric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)in

PartnerEric De La Fortelle· solo GP

Tissiumtissium.com𝕏

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.

BiotechDeep TechMedical DevicesNew Materials

Unknown founder(s)Christophe Bancel(Co-founder & CEO)Maria Pereira(Co-inventor of the technology; leads the Innovation Hub)

PartnerEric De La Fortelle· solo GP

Frequently asked questions

What stage does Cathay Health invest at?
Cathay Health invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Cathay Health focus on?
Cathay Health focuses on Advanced Manufacturing, Biotech, Consumer, Crypto & Web3, Deep Tech, Digital Health, Healthtech, Medical Devices, New Materials, Robotics.
Where is Cathay Health located?
Cathay Health is headquartered in San Francisco, US.

Images

Cathay Health photoCathay Health photo

Similar investors

Featured in lists